Palvella Therapeutics PVLA Cash Flow Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| -$41.72M-177% | -$15.08M-181% | $18.69M+156% | -$33.28M+27.2% | ||
| $6.4M+671% | $830K— | —— | $4.4M-15.6% | ||
| -$25.01M-131% | -$10.84M— | —— | -$59.93M-682% | ||
| —— | —— | —— | —— | ||
| —— | $87.09M— | —— | $7.21M-87.8% | ||
| -$25.62M-133% | $76.58M+980% | -$8.7M+89.0% | -$79.13M— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Palvella Therapeutics generate?
- Palvella Therapeutics (PVLA) generated -$29.1M in operating cash flow over the trailing twelve months.
- What is Palvella Therapeutics's free cash flow?
- Palvella Therapeutics's free cash flow was -$15.2M over the trailing twelve months, up 67.1% year over year.
- Where does Palvella Therapeutics's cash flow data come from?
- Every line is extracted from Palvella Therapeutics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
